Enhancement Patterns of Hepatocellular Carcinomas on Multiphasicmultidetector Row CT: Comparison with Pathological Differentiation

Overview

Journal Br J Radiol

Publisher Oxford University Press

Specialty Radiology

Date 2012 Aug 25

PMID 22919011

Citations 54

Authors

J H Lee

J M Lee

S J Kim

J H Baek

S H Yun

K W Kim

J K Han

B I Choi

Affiliations

Soon will be listed here.

Abstract

Objective: The objective of this study was to determine the incidence of typical and atypical enhancement patterns of hepatocellular carcinomas (HCCs) on multiphasic multidetector row CT (MDCT) and to correlate the enhancement patterns and morphological image findings of HCC with the degree of tumour differentiation.

Methods: MDCT images of 217 patients with 243 surgically proven HCCs were evaluated through consensus reading by two radiologists. Our MDCT protocol was composed of precontrast, arterial, portal and delayed phases. The reviewers analysed the CT images for degree of attenuation; relative timing of washout; presence of dysmorphic intratumoral vessels, aneurysms and necrosis; tumour size; tumour margin; presence of pseudocapsule; intratumoral heterogeneity; and determined enhancement pattern. The imaging features were correlated with tumour differentiation using Fisher's exact test or the χ(2) test.

Results: Among 243 HCCs, 137 (56.4%) showed the typical enhancement pattern of HCC, which is arterial enhancement and washout on portal or equilibrium phase images. In the arterial phase, 190 of 243 (78.2%) HCCs showed hypervascularity, with approximately three quarters of poorly differentiated (PD) (34 of 45, 75.6%) and moderately differentiated (MD) HCCs (92 of 123, 74.8%) showing washout during the portal or delayed phases, vs only 50% of well-differentiated (WD) HCCs (11 of 22; p<0.048). The presence of intratumoral vessels and aneurysms, tumour necrosis, attenuation of precontrast, the relative timing of washout, intratumoral attenuation heterogeneity, tumour margin and tumour size were correlated with the pathological differentiation of HCCs (p<0.05).

Conclusion: A typical enhancement of HCCs on MDCT was not unusual (43.6%) and WD and PD HCCs account for most of the atypical enhancement patterns. Early washout favoured MD and PD HCCs rather than WD HCCs, whereas in our study the presence of intratumoral aneurysm was a highly specific finding for PD HCC.

Citing Articles

Magnetic resonance imaging of hepatocellular carcinoma: a spectrum of uncommon morphologic subtypes, unusual imaging patterns and mimics.

Wang M, Siddiqui M, Roudenko A, Kamath A, Chaudhry H, Ram R Abdom Radiol (NY). 2025; .

PMID: 39753921 DOI: 10.1007/s00261-024-04773-z.

Alpha-fetoprotein-to-PIVKA-II ratio as a potential biomarker for hepatocellular carcinoma differentiation, imaging characteristics, and patient survival.

Dieu-Merci M, Hu J, Fang X, Zhao R, Xie X, Pan W Transl Cancer Res. 2024; 13(11):5929-5942.

PMID: 39697743 PMC: 11651849. DOI: 10.21037/tcr-24-958.

Clinical and Radiologic Predictors of Response to Atezolizumab-Bevacizumab in Advanced Hepatocellular Carcinoma.

Choi S, Chung S, Choi J, Kim K, Kim H, Yoo C Cancer Res Treat. 2024; 56(4):1219-1230.

PMID: 38726509 PMC: 11491262. DOI: 10.4143/crt.2024.283.

CT-based radiomics for predicting pathological grade in hepatocellular carcinoma.

Huang Y, Chen L, Ding Q, Zhang H, Zhong Y, Zhang X Front Oncol. 2024; 14:1295575.

PMID: 38690170 PMC: 11059035. DOI: 10.3389/fonc.2024.1295575.

Clinical prediction of microvascular invasion in hepatocellular carcinoma using an MRI-based graph convolutional network model integrated with nomogram.

Liu Y, Zhang Z, Zhang H, Wang X, Wang K, Yang R Br J Radiol. 2024; 97(1157):938-946.

PMID: 38552308 PMC: 11075980. DOI: 10.1093/bjr/tqae056.

References

Jang H, Kim T, Burns P, Wilson S . Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology. 2007; 244(3):898-906. DOI: 10.1148/radiol.2443061520. View

Woodall C, Scoggins C, Loehle J, Ravindra K, McMasters K, Martin R . Hepatic imaging characteristics predict overall survival in hepatocellular carcinoma. Ann Surg Oncol. 2007; 14(10):2824-30. DOI: 10.1245/s10434-007-9525-2. View

Nino-Murcia M, Olcott E, Jeffrey Jr R, Lamm R, Beaulieu C, Jain K . Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT. Radiology. 2000; 215(3):746-51. DOI: 10.1148/radiology.215.3.r00jn03746. View

EDMONDSON H, STEINER P . Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954; 7(3):462-503. DOI: 10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e. View

Amano S, Ebara M, Yajima T, Fukuda H, Yoshikawa M, Sugiura N . Assessment of cancer cell differentiation in small hepatocellular carcinoma by computed tomography and magnetic resonance imaging. J Gastroenterol Hepatol. 2003; 18(3):273-9. DOI: 10.1046/j.1440-1746.2003.02957.x. View

El-Serag H, Mason A . Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999; 340(10):745-50. DOI: 10.1056/NEJM199903113401001. View

Marrero J, Hussain H, Nghiem H, Umar R, Fontana R, Lok A . Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl. 2005; 11(3):281-9. DOI: 10.1002/lt.20357. View

Doyle D, OMalley M, Jang H, Jhaveri K . Value of the unenhanced phase for detection of hepatocellular carcinomas 3 cm or less when performing multiphase computed tomography in patients with cirrhosis. J Comput Assist Tomogr. 2007; 31(1):86-92. DOI: 10.1097/01.rct.0000233126.21303.f0. View

Park H, Lee J, Kim S, Chang S, Kim S, Han J . Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla. J Magn Reson Imaging. 2009; 29(2):328-35. DOI: 10.1002/jmri.21615. View

10.

Leoni S, Piscaglia F, Golfieri R, Camaggi V, Vidili G, Pini P . The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol. 2009; 105(3):599-609. DOI: 10.1038/ajg.2009.654. View

11.

Jonas S, Bechstein W, Steinmuller T, Herrmann M, Radke C, Berg T . Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology. 2001; 33(5):1080-6. DOI: 10.1053/jhep.2001.23561. View

12.

Liu G, Xu H, Lu M, Xie X, Xu Z, Zheng Y . Correlation between enhancement pattern of hepatocellular carcinoma on real-time contrast-enhanced ultrasound and tumour cellular differentiation on histopathology. Br J Radiol. 2006; 80(953):321-30. DOI: 10.1259/bjr/54805002. View

13.

Oishi K, Itamoto T, Amano H, Fukuda S, Ohdan H, Tashiro H . Clinicopathologic features of poorly differentiated hepatocellular carcinoma. J Surg Oncol. 2007; 95(4):311-6. DOI: 10.1002/jso.20661. View

14.

Furlan A, Marin D, Vanzulli A, Patera G, Ronzoni A, Midiri M . Hepatocellular carcinoma in cirrhotic patients at multidetector CT: hepatic venous phase versus delayed phase for the detection of tumour washout. Br J Radiol. 2010; 84(1001):403-12. PMC: 3473662. DOI: 10.1259/bjr/18329080. View

15.

Kudo M . Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol. 2009; 44 Suppl 19:112-8. DOI: 10.1007/s00535-008-2274-6. View

16.

Forner A, Vilana R, Ayuso C, Bianchi L, Sole M, Ayuso J . Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2007; 47(1):97-104. DOI: 10.1002/hep.21966. View

17.

. Terminology of nodular hepatocellular lesions. Hepatology. 1995; 22(3):983-93. DOI: 10.1016/0270-9139(95)90324-0. View

18.

Honda H, Tajima T, Kajiyama K, Kuroiwa T, Yoshimitsu K, Irie H . Vascular changes in hepatocellular carcinoma: correlation of radiologic and pathologic findings. AJR Am J Roentgenol. 1999; 173(5):1213-7. DOI: 10.2214/ajr.173.5.10541091. View

19.

Hoon Lim J, Choi D, Park C, Lee W, Lim H . Encapsulated hepatocellular carcinoma: CT-pathologic correlations. Eur Radiol. 2006; 16(10):2326-33. DOI: 10.1007/s00330-006-0203-8. View

20.

Yoon S, Lee J, So Y, Hong S, Kim S, Han J . Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation. AJR Am J Roentgenol. 2009; 193(6):W482-9. DOI: 10.2214/AJR.08.1818. View